Phase 2 ARCHER Data Support Therapeutic Potential for ANX007 to Preserve Vision in Patients who have Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA) Phase 3 ARCHER II Trial ...

Researchers reviewed the course of bacillary layer detachment in treatment naive eyes undergoing aflibercept injections.

Researchers investigated the concurrent validity of various visual function measures in differentiating early and ...

Johnson & Johnson bought the full rights to a rare disease gene therapy a few years ago, but now the Big Pharma may be ...

Award-winning research shows RevitalVision improves vision in keratoconus and post-cataract patients, highlighting rising ...

Researchers have found in a new study involving 89 amblyopia patients, including adults, that visual acuity gradually ...

Alex Hacopian, MD, highlights how a recent ambispective study demonstrated strong visual acuity outcomes and patient ...